2017 Annual Meeting | C97 - The Dystonias: Diagnosis, Treatment, and Update on Causes
03:30 PM - 04:10 PM | Speaker |
Clinical Features and Classification of the Dystonias
Daniel Tarsy, MD, FAAN |
04:10 PM - 04:50 PM | Speaker |
The Medical and Surgical Treatment of Dystonia
Samuel A. Frank, MD, FAAN |
04:50 PM - 05:30 PM | Speaker |
Pathophysiology and Etiology of Dystonia
Rachel J. Saunders-Pullman, MD |
Samuel A. Frank, MD, FAAN | Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel. |
Daniel Tarsy, MD, FAAN | No disclosure on file |
Rachel J. Saunders-Pullman, MD | The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program. |